You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

Drugs Containing Excipient (Inactive Ingredient) ALCOHOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing ALCOHOL excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Eli Lilly and Company AMYVID florbetapir f 18 0002-1200 ALCOHOL 2027-04-30
Eli Lilly and Company RETEVMO selpercatinib 0002-3977 ALCOHOL 2038-10-10
ER Squibb & Sons LLC REYATAZ atazanavir 0003-3624 ALCOHOL
Eli Lilly and Company TAUVID flortaucipir f-18 0002-1210 ALCOHOL 2032-05-26
Eli Lilly and Company TAUVID flortaucipir f-18 0002-1220 ALCOHOL 2032-05-26
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 5 of 5 entries

Generic drugs containing ALCOHOL excipient

Alcohol Excipients in the Pharmaceutical Industry: Market Dynamics and Financial Trajectory

Introduction to Alcohol Excipients

Alcohol excipients are crucial components in the pharmaceutical industry, serving as carriers or stabilizers for active ingredients in medications. These excipients, such as cetyl alcohol, glycerol, and ethanol, play a vital role in ensuring the stability, biopharmaceutical profile, and patient acceptability of pharmaceutical products.

Market Overview

The alcohol excipients market has been experiencing significant growth, driven primarily by the expanding pharmaceutical sector. As of 2023, the market was valued at USD 2.47 billion and is projected to reach USD 3.85 billion by 2030, with a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period of 2024-2030[1].

Market Segmentation

By Product

The alcohol excipients market is segmented into several product categories, including sorbitol, glycerin, and others. In 2023, the sorbitol segment dominated the market, holding a significant share of the overall revenue. This dominance is expected to continue due to the increasing consumption of sorbitol in pharmaceutical applications[1].

By Application

The market is also segmented by application, with the pharmaceutical segment being the most dominant. In 2020, the pharmaceutical segment held more than 70% of the overall market share, largely due to the increased production of medicines and vaccines during the COVID-19 pandemic. This trend is anticipated to persist, driving the growth of alcohol excipients globally[1].

Regional Insights

Geographically, the Asia Pacific region is a key player in the alcohol excipients market, holding a significant market share in 2023. This region's growth is supported by the presence of major pharmaceutical companies such as Cipla, Pfizer, and Novartis, as well as an increasing population with rising health issues[1].

Drivers of Market Growth

Several factors are driving the growth of the alcohol excipients market:

COVID-19 Pandemic Impact

The COVID-19 pandemic has significantly boosted the pharmaceutical industry, leading to an increased demand for high-quality drugs and vaccines. This surge in pharmaceutical production has consequently driven the consumption of alcohol excipients[1].

Growing Pharmaceutical Industry

The expanding pharmaceutical industry, particularly in emerging economies like India, China, and Brazil, is a major driver. The development of new excipients and the growing application scope of existing ones, such as glycerin, are also contributing to market growth[4].

Increasing Demand for High-Quality Drugs

The rising demand for high-quality drugs, especially in regions with growing populations and increasing health issues, is another key factor driving the market[1].

Challenges and Regulatory Risks

Despite the growth, the market faces several challenges:

Regulatory Risks

Strict regulations and guidelines governing drug examinations and the use of excipients can hinder market growth. For instance, certain alcohol excipients may result in side effects, necessitating careful regulatory oversight[1][4].

Quality and Stability Requirements

Ensuring the quality and stability of excipients is crucial. Guidelines such as those from the European Medicines Agency emphasize the need for in-use stability studies to justify the shelf life of medicinal products, which can be a complex and stringent process[2].

Financial Trajectory

The financial outlook for the alcohol excipients market is promising:

  • Current Market Size: The market was valued at USD 2.47 billion in 2023[1].
  • Projected Market Size: Expected to reach USD 3.85 billion by 2030[1].
  • CAGR: Anticipated to grow at a CAGR of 6.5% from 2024 to 2030[1].

Competitive Landscape

The market is characterized by the presence of several key players, including Associated British Foods, Archer Daniels Midland, and J.M. Huber Corporation. These companies are known for their strong product portfolios and strategic growth initiatives[1].

Future Opportunities

The future of the alcohol excipients market looks promising, with several opportunities on the horizon:

Emerging Economies

The growth of pharmaceutical industries in emerging economies such as India, China, and Brazil is expected to boost the demand for alcohol excipients in oral solid dosage forms (OSDF)[4].

Development of New Excipients

The ongoing development of new excipients and the expanding application scope of existing ones, such as glycerin, are expected to drive market growth in the coming years[4].

Key Takeaways

  • The alcohol excipients market is projected to grow significantly, driven by the pharmaceutical industry's expansion.
  • The sorbitol segment is expected to dominate the market due to its increasing consumption in pharmaceutical applications.
  • The Asia Pacific region is a key market, driven by the presence of major pharmaceutical companies and a growing population.
  • Regulatory risks and quality requirements are critical factors that need careful management.
  • Emerging economies and the development of new excipients present significant future opportunities.

FAQs

What is the forecasted market size of the alcohol excipients market by 2030?

The alcohol excipients market is expected to reach USD 3.85 billion by 2030[1].

What is the CAGR of the alcohol excipients market from 2024 to 2030?

The market is anticipated to grow at a CAGR of 6.5% from 2024 to 2030[1].

Which segment dominates the alcohol excipients market by product?

The sorbitol segment dominates the market and is expected to continue its dominance over the forecast period[1].

What are the key drivers of the alcohol excipients market?

The key drivers include the growth of the pharmaceutical industry, the impact of the COVID-19 pandemic, and the increasing demand for high-quality drugs[1][4].

Which region holds the largest market share in the alcohol excipients market?

The Asia Pacific region holds a significant market share, driven by the presence of major pharmaceutical companies and a growing population[1].

Sources

  1. Maximize Market Research: "Alcohol Excipients Market: Industry Analysis and Forecast"
  2. European Medicines Agency: "Quality of medicines questions and answers: Part 2"
  3. BioSpace: "Pharmaceutical Excipients Market Size USD 14.72 Billion by 2033 ..."
  4. Grand View Research: "Alcohol Excipients Market Size, Share | Global Industry Report, 2025"
  5. GlobeNewswire: "Global Excipients (Polymers, Alcohols, Sugars, Minerals, Gelatin) Market Analysis 2023-2030"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.